Incidence and impact on prognosis of peri-procedural myocardial infarction in 2760 elective patients with stable angina pectoris in a historical prospective follow-up study

BMC Cardiovascular Disorders

Volumn 16, Issue 1, 2016, Pages

  Christensen, Martin Kirk ^a   Huang, Hui ^a   Torp Pedersen, Christian ^b   Trydal, Torleif ^a   Ravkilde, Jan ^a  

^a AALBORG UNIVERSITY HOSPITAL   (Denmark)

^b AALBORG UNIVERSITY   (Denmark)

Author keywords

Elective; Myocardial infarction; Percutaneous coronary intervention; Peri procedural; Prognosis; Troponin

Indexed keywords

BIOLOGICAL MARKER; CREATINE KINASE MB; CREATININE; TROPONIN T;

AGE; AGED; ARTICLE; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DENMARK; DIABETES MELLITUS; DISEASE SEVERITY; FAMILY HISTORY; FEMALE; FOLLOW UP; GENDER; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; INCIDENCE; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; SMOKING; STABLE ANGINA PECTORIS; ADVERSE EFFECTS; ANGINA, STABLE; BLOOD; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODEL; RISK ASSESSMENT; RISK FACTOR; TIME FACTOR; TREATMENT OUTCOME; UNIVERSITY HOSPITAL;

AGED; ANGINA, STABLE; BIOMARKERS; CREATINE KINASE, MB FORM; DENMARK; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HOSPITALS, UNIVERSITY; HUMANS; INCIDENCE; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME; TROPONIN T;

EID: 84975318177     PISSN: None     EISSN: 14712261     Source Type: Journal    
DOI: 10.1186/s12872-016-0293-4     Document Type: Article

References (30)

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD. ESC/ACCF/AHA/WHF Expert Consensus Document Third Universal Definition of Myocardial Infarction. 2012.
2. Moussa ID, Klein LW, Shah B, Mehran R, Mack MJ, Brilakis ES, Reilly JP, Zoghbi G, Holper E, Stone GW. Consideration of a new definition of clinically relevant myocardial infarction after coronary revascularization: an expert consensus document from the Society for Cardiovascular Angiography and Interventions (SCAI). J Am Coll Cardiol. 2013;62:1563-70.
3. Akkerhuis KM, Alexander JH, Tardiff BE, Boersma E, Harrington RA, Lincoff AM, Simoons ML. Minor myocardial damage and prognosis: are spontaneous and percutaneous coronary intervention-related events different? Circulation. 2002;105:554-6.
4. Abdelmeguid AE, Whitlow PL, Sapp SK, Ellis SG, Topol EJ. Long-term outcome of transient, uncomplicated in-laboratory coronary artery closure. Circulation. 1995;91:2733-41.
5. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem. 2010;56:254-61.
6. Apple FS, Quist HE, Doyle PJ, Otto AP, Murakami MM. Plasma 99th percentile reference limits for cardiac troponin and creatine kinase MB mass for use with European Society of Cardiology/American College of Cardiology consensus recommendations. Clin Chem. 2003;49:1331-6.
7. Grann AF, Erichsen R, Nielsen AG, Frøslev T, Thomsen RW. Existing data sources for clinical epidemiology: The clinical laboratory information system (LABKA) research database at Aarhus University, Denmark. Clin Epidemiol. 2011;3:133-8.
8. Schmidt M, Maeng M, Jakobsen C-J, Madsen M, Thuesen L, Nielsen PH, Bøtker HE, Sørensen HT. Existing data sources for clinical epidemiology: The Western Denmark Heart Registry. Clin Epidemiol. 2010;2:137-44.
9. Pedersen CB. The Danish Civil Registration System. Scand J Public Health. 2011;39(7 Suppl):22-5.
10. Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38-41.
11. R Development Core Team. R: A Language and Environment for Statistical Computing. Vienna, Austria: the R Foundation for Statistical Computing; 2011.
12. Testa L, Van Gaal WJ, Biondi Zoccai GGL, Agostoni P, Latini RA, Bedogni F, Porto I, Banning AP. Myocardial infarction after percutaneous coronary intervention: a meta-analysis of troponin elevation applying the new universal definition. QJM. 2009;102:369-78.
13. Thygesen K, Alpert JS, White HD. Universal definition of myocardial infarction. Eur Heart J. 2007;28:2525-38.
14. Muschart X, Slimani A, Jamart J, Chenu P, Dangoisse V, Gabriel L, Guédès A, Marchandise B, Schröder E. The different mechanisms of periprocedural myocardial infarction and their impact on in-hospital outcome. J Invasive Cardiol. 2012;24:655-60.
15. White HD. The prequel: defining prognostically important criteria in the periprocedural PCI troponin saga. Circ Cardiovasc Interv. 2012;5:142-5.
16. Prasad A, Rihal CS, Lennon RJ, Singh M, Jaffe AS, Holmes DR. Significance of periprocedural myonecrosis on outcomes after percutaneous coronary intervention: an analysis of preintervention and postintervention troponin T levels in 5487 patients. Circ Cardiovasc Interv. 2008;1:10-9.
17. Cavallini C, Verdecchia P, Savonitto S, Arraiz G, Violini R, Olivari Z, Rubartelli P, De Servi S, Plebani M, Steffenino G, Sbarzaglia P, Ardissino D. Prognostic value of isolated troponin I elevation after percutaneous coronary intervention. Circ Cardiovasc Interv. 2010;3:431-5.
18. Prasad A. Slow but steady progress towards understanding peri-procedural myocardial infarction. Eur Heart J. 2013;34:1615-7.
19. Selvanayagam JB, Porto I, Channon K, Petersen SE, Francis JM, Neubauer S, Banning AP. Troponin elevation after percutaneous coronary intervention directly represents the extent of irreversible myocardial injury: insights from cardiovascular magnetic resonance imaging. Circulation. 2005;111:1027-32.
20. Califf RM, Abdelmeguid AE, Kuntz RE, Popma JJ, Davidson CJ, Cohen EA, Kleiman NS, Mahaffey KW, Topol EJ, Pepine CJ, Lipicky RJ, Granger CB, Harrington RA, Tardiff BE, Crenshaw BS, Bauman RP, Zuckerman BD, Chaitman BR, Bittl JA, Ohman EM. Myonecrosis after revascularization procedures. J Am Coll Cardiol. 1998;31:241-51.
21. Lee C-H, Tse H-F. Microvascular obstruction after percutaneous coronary intervention. Catheter Cardiovasc Interv. 2010;75:369-77.
22. Feldman DN, Kim L, Rene AG, Minutello RM, Bergman G, Wong SC. Prognostic value of cardiac troponin-I or troponin-T elevation following nonemergent percutaneous coronary intervention: a meta-analysis. Catheter Cardiovasc Interv. 2011;77:1020-30.
23. Park D-W, Kim Y-H, Yun S-C, Ahn J-M, Lee J-Y, Kim W-J, Kang S-J, Lee S-W, Lee CW, Park S-W, Park S-J. Frequency, causes, predictors, and clinical significance of peri-procedural myocardial infarction following percutaneous coronary intervention. Eur Heart J. 2013;34:1662-9.
24. Jaffe AS, Apple FS, Lindahl B, Mueller C, Katus HA. Why all the struggle about CK-MB and PCI? Eur Heart J. 2012;33:1046-8.
25. Hallén J. Troponin for the estimation of infarct size: what have we learned? Cardiology. 2012;121:204-12.
26. Savonitto S, Granger CB, Ardissino D, Gardner L, Cavallini C, Galvani M, Ottani F, White HD, Armstrong PW, Ohman EM, Pieper KS, Califf RM, Topol EJ. The prognostic value of creatine kinase elevations extends across the whole spectrum of acute coronary syndromes. J Am Coll Cardiol. 2002;39:22-9.
27. Kanaparti PK, Brown DL. Atherosclerotic Plaque Burden and Percutaneous Coronary Intervention. Am J Cardiol. 2000;86:619-22.
28. Jeremias A, Baim DS, Ho KKL, Chauhan M, Carrozza JP, Cohen DJ, Popma JJ, Kuntz RE, Cutlip DE. Differential mortality risk of postprocedural creatine kinase-MB elevation following successful versus unsuccessful stent procedures. J Am Coll Cardiol. 2004;44:1210-4.
29. Lindsey JB, Kennedy KF, Stolker JM, Gilchrist IC, Mukherjee D, Marso SP, Pencina MJ, Kleiman NS, Cohen DJ. Prognostic implications of creatine kinase-MB elevation after percutaneous coronary intervention: results from the Evaluation of Drug-Eluting Stents and Ischemic Events (EVENT) registry. Circ Cardiovasc Interv. 2011;4:474-80.
30. Kümler T, Hilmar G, Kirk V, Bay M, Nielsen OW, Køber L, Torp-pedersen C. Accuracy of a heart failure diagnosis in administrative registers. Eur J Heart Fail. 2008;10(7):658-660.